These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20382349)

  • 41. Murine CD8+ regulatory T lymphocytes: the new era.
    Pomié C; Ménager-Marcq I; van Meerwijk JP
    Hum Immunol; 2008 Nov; 69(11):708-14. PubMed ID: 18817827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial progenitor cells: biology and therapeutic potential in hypertension.
    van Zonneveld AJ; Rabelink TJ
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):167-72. PubMed ID: 16481884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory T cells in autoimmune endocrine diseases.
    Wong FS; Dayan CM
    Trends Endocrinol Metab; 2008 Oct; 19(8):292-9. PubMed ID: 18786834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive therapy in the obese hypertensive patient.
    Chrostowska M; Szczech R; Narkiewicz K
    Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):487-92. PubMed ID: 16914960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total cardiovascular risk: a new treatment concept.
    Mancia G
    J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune regulation by regulatory T cells: implications for transplantation.
    Jonuleit H; Adema G; Schmitt E
    Transpl Immunol; 2003; 11(3-4):267-76. PubMed ID: 12967780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
    Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
    Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
    Safar ME; Struijker-Boudier HA
    Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
    Madhur MS; Elijovich F; Alexander MR; Pitzer A; Ishimwe J; Van Beusecum JP; Patrick DM; Smart CD; Kleyman TR; Kingery J; Peck RN; Laffer CL; Kirabo A
    Circ Res; 2021 Apr; 128(7):908-933. PubMed ID: 33793336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aldosterone as a modulator of immunity: implications in the organ damage.
    Herrada AA; Campino C; Amador CA; Michea LF; Fardella CE; Kalergis AM
    J Hypertens; 2011 Sep; 29(9):1684-92. PubMed ID: 21826023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neural regulation of the immune system modulates hypertension-induced target-organ damage.
    Luft FC
    J Am Soc Hypertens; 2012; 6(1):23-6. PubMed ID: 22047671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basic science: hypertensive target organ damage.
    Bidani AK; Griffin KA
    J Am Soc Hypertens; 2015 Mar; 9(3):235-7; quiz 238. PubMed ID: 25670252
    [No Abstract]   [Full Text] [Related]  

  • 54. Mitochondrial injury and dysfunction in hypertension-induced cardiac damage.
    Eirin A; Lerman A; Lerman LO
    Eur Heart J; 2014 Dec; 35(46):3258-66. PubMed ID: 25385092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent Advances in Immunity and Hypertension.
    Lopez Gelston CA; Mitchell BM
    Am J Hypertens; 2017 Jul; 30(7):643-652. PubMed ID: 28200062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertension: a new treatment for an old disease? Targeting the immune system.
    Bomfim GF; Cau SBA; Bruno AS; Fedoce AG; Carneiro FS
    Br J Pharmacol; 2019 Jun; 176(12):2028-2048. PubMed ID: 29969833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune Mechanisms in Arterial Hypertension.
    Wenzel U; Turner JE; Krebs C; Kurts C; Harrison DG; Ehmke H
    J Am Soc Nephrol; 2016 Mar; 27(3):677-86. PubMed ID: 26319245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective.
    Murray EC; Nosalski R; MacRitchie N; Tomaszewski M; Maffia P; Harrison DG; Guzik TJ
    Cardiovasc Res; 2021 Nov; 117(13):2589-2609. PubMed ID: 34698811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of T-cell activation in salt-sensitive hypertension.
    Ren J; Crowley SD
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1345-H1353. PubMed ID: 30901277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sympathetic-mediated activation versus suppression of the immune system: consequences for hypertension.
    Case AJ; Zimmerman MC
    J Physiol; 2016 Feb; 594(3):527-36. PubMed ID: 26830047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.